Back to Trades
Hill Christopher James
Chief Financial OfficerCIK 0002090619
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Hill Christopher James, Chief Financial Officer, accounts for 1 disclosed filing worth $0, all concentrated in Adaptimmune Therapeutics PLC (ADAP), active 2025. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Oct 8 | ADAP Adaptimmune Therapeutics PLC | Hill Christopher James | Chief Financial Officer | Other | $0 |
1 filing